Clinical Trial Update: The Effects of EPA/DHA Supplementation on Cognitive Control in Children With ADHD [NA]

View source ↗

Summary

A completed clinical trial evaluated whether EPA/DHA omega-3 supplementation improves cognitive control in children with ADHD. The study was sponsored by Unilev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• EPA/DHA omega-3 supplementation (eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA))

Snippet

Sponsor: Unilever R&D | Conditions: Attention Deficit Hyperactivity Disorder, Healthy | NA | Status: COMPLETED